本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

德康医疗

58.06
-1.6600-2.78%
盘前58.00-0.0600-0.10%08:57 EST
成交量:537.53万
成交额:3.15亿
市值:226.44亿
市盈率:32.31
高:59.47
开:59.05
低:57.92
收:59.72
52周最高:93.25
52周最低:54.11
股本:3.90亿
流通股本:3.90亿
量比:0.62
换手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):1.80
每股收益(LYR):1.46
净资产收益率:30.63%
总资产收益率:7.02%
市净率:8.31
市盈率(LYR):39.66

数据加载中...

2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/27

重要事件披露

Form 8-K - Current report
2025/09/16

重要事件披露

Form 8-K - Current report
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities